Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial. [electronic resource] by
- Gligorov, Joseph
- Curigliano, Giuseppe
- Müller, Volkmar
- Knoop, Ann
- Jenkins, Valerie
- Verma, Sunil
- Osborne, Stuart
- Lauer, Sabine
- Machackova, Zuzana
- Fallowfield, Lesley
- Pivot, Xavier
Producer: 20180410
In:
Breast (Edinburgh, Scotland) vol. 34
Availability: No items available.
|
|
8.
|
Adjuvant Subcutaneous Trastuzumab for HER2-Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study. [electronic resource] by
- Jung, Kyung Hae
- Ataseven, Beyhan
- Verrill, Mark
- Pivot, Xavier
- De Laurentiis, Michelino
- Al-Sakaff, Nedal
- Lauer, Sabine
- Shing, Mona
- Gligorov, Joseph
- Azim, Hamdy A
Producer: 20190926
In:
The oncologist vol. 23
Availability: No items available.
|
|
9.
|
|
|
10.
|
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. [electronic resource] by
- Cameron, David
- Piccart-Gebhart, Martine J
- Gelber, Richard D
- Procter, Marion
- Goldhirsch, Aron
- de Azambuja, Evandro
- Castro, Gilberto
- Untch, Michael
- Smith, Ian
- Gianni, Luca
- Baselga, Jose
- Al-Sakaff, Nedal
- Lauer, Sabine
- McFadden, Eleanor
- Leyland-Jones, Brian
- Bell, Richard
- Dowsett, Mitch
- Jackisch, Christian
Producer: 20180416
In:
Lancet (London, England) vol. 389
Availability: No items available.
|